We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$94.3B
AUM Growth
+$7.96B
Cap. Flow
-$2.37B
Cap. Flow %
-2.52%
Top 10 Hldgs %
12.56%
Holding
2,315
New
140
Increased
934
Reduced
1,002
Closed
155

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$335M
2
EXC icon
Exelon
EXC
+$314M
3
PG icon
Procter & Gamble
PG
+$241M
4
TRIP icon
TripAdvisor
TRIP
+$208M
5
SBUX icon
Starbucks
SBUX
+$182M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$551M
2
TGT icon
Target
TGT
+$514M
3
CELG
Celgene Corp
CELG
+$495M
4
CI icon
Cigna
CI
+$369M
5
COST icon
Costco
COST
+$310M

Sector Composition

Rank Sector Weight
1 Technology 19.77%
2 Healthcare 19.09%
3 Consumer Discretionary 13.69%
4 Industrials 9.28%
5 Financials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
2226
Wave Life Sciences
WVE
$1.2B
-12,624
Closed -$531K
XXII
2227
22nd Century Group
XXII
$1.48M
0
-$75K
Z icon
2228
Zillow
Z
$7.56B
-15,964
Closed -$504K
ZLAB icon
2229
Zai Lab
ZLAB
$2.62B
-8,780
Closed -$204K
NPKI
2230
NPK International
NPKI
$1.14B
-14,129
Closed -$97K
TVRD
2231
Tvardi Therapeutics
TVRD
$23.4M
-293
Closed -$137K
LGF.A
2232
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-37,131
Closed -$598K
ITCI
2233
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-19,837
Closed -$226K
B
2234
DELISTED
Barnes Group Inc.
B
-17,685
Closed -$948K
CHUY
2235
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
-10,327
Closed -$183K
DCPH
2236
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-10,312
Closed -$216K
CBAY
2237
DELISTED
Cymabay Therapeutics
CBAY
-21,993
Closed -$173K
CCF
2238
DELISTED
Chase Corporation
CCF
-2,095
Closed -$210K
TWNK
2239
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-18,650
Closed -$204K
RAD
2240
DELISTED
Rite Aid Corporation
RAD
-3,411
Closed -$48K
AMRS
2241
DELISTED
Amyris Inc.
AMRS
-57,131
Closed -$191K
PDCE
2242
DELISTED
PDC Energy, Inc.
PDCE
-34,142
Closed -$1.02M
VRAY
2243
DELISTED
ViewRay, Inc.
VRAY
-22,400
Closed -$136K
AIMC
2244
DELISTED
Altra Industrial Motion Corp
AIMC
-9,033
Closed -$227K
CLR
2245
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-27,107
Closed -$1.09M
ZVO
2246
DELISTED
Zovio Inc. Common Stock
ZVO
-61,198
Closed -$429K
GBT
2247
DELISTED
Global Blood Therapeutics, Inc.
GBT
-8,390
Closed -$344K
POLY
2248
DELISTED
Plantronics, Inc.
POLY
-16,069
Closed -$532K
SREV
2249
DELISTED
ServiceSource International, Inc.
SREV
-38,337
Closed -$41K
FLOW
2250
DELISTED
SPX FLOW, Inc.
FLOW
-8,002
Closed -$243K

Similar funds

AQR Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, AQR Capital Management held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

AQR Capital Management's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AQR Capital Management's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
  • AQR Capital Management added most to Biogen in Q1 2019, an estimated $335M increase.
  • AQR Capital Management's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
  • AQR Capital Management fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
  • AQR Capital Management's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
  • AQR Capital Management opened 140 new positions and closed 155 in Q1 2019.
  • AQR Capital Management's portfolio value rose 9.2% quarter-over-quarter to $94.3B.

Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.